Depression needs to be defined at the neurobiological level in order to improve the efficiency of treatment and reduce the burden of depressive disorders.
Neurobiological markers of depression may help psychiatrists to target specific neural processes and regions involved in affective regulation and to tailor antidepressant treatment according to the biological needs of the patients.
This could improve patientsī chances to responding to specific treatment modalities.
The results were presented at a press conference on the occasion of the 23rd ECNP Congress, Amsterdam.
Source-ANI